CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies ...

BioStem Technologies offers strong YoY growth, profitability, and innovation in regenerative medicine. Read more to see why ...

Adia Nutrition, Inc. (OTCQB: ADIA), a pioneer in regenerative medicine and nutritional supplements, is excited to announce the addition of licensing agreements to its business model, driven by strong ...

The Tissue Engineered Skin Substitute Market is projected to be worth USD 2.4 billion in 2024. The market is anticipated to reach USD 3.5 billion by 2034. The market is further expected to surge at a ...

This article explores the current landscape and future potential of cell therapies, including CAR T-cell and stem cell-based ...

Alcon posts steady growth in Vision Care and Surgical, with new drug and therapy launches ahead but execution risks persist.

The amniotic membrane market is estimated to stand at USD 1,510.6 million in 2024. The market is forecasted to exceed a valuation of USD 2,279.5 million by 2034, recording a CAGR of 4.2%. Amniotic ...

The U.S. health secretary said people should have access to experimental therapies including unregulated uses of stem cells.

HCCs represent a new frontier in hyaluronic acid-based product formulation, made possible through NAHYCO® Technology, IBSA’s ...

Medical equipment company Smith & Nephew has agreed a $660 million deal to buy US biotech Osiris Therapeutics that expands its business into regenerative medicine. Osiris makes medical products ...

Best exosome skincare products for youthful, radiant skin - Exosomes are revolutionising skincare with their ability to ...